PATENT CLAIM ANALYSIS

Application Number: 16171914
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "499000"]

Abstract:
This document discloses a powder formulation of lamotrigine for oral administration. Also disclosed is a suspension of lamotrigine and a method of treating diseases.

Claim (Index 6):
The powder formulation of  claim 1 , wherein the suspending agent is selected from the group consisting of hydrocolloid gum, cellulosic derivative, a polysaccharide, alginate, acrylic acid copolymer, polyvmylpyrrohdone, aluminiummagnesium silicate, and any combination thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.3
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14353141', '15850732', '15433743', '13914452', '14994497']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7599116818613476
- 35 USC 102 Novelty (BERT): 0.500711289890619
- Combined Prediction Score: 0.7339916426642747
- Mean Citation Score: 225.60928
- Max Citation Score: 228.18468
- Similarity Product: 148.0394234759474

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test